haemangiomas: insights into the molecular mechanisms of action. Br. J. Dermatol. 2010; 163: 269–74. 4 Chiu YE, Drolet BA, Blei F et al. Variable response to propranolol treatment of kaposiform… Click to show full abstract
haemangiomas: insights into the molecular mechanisms of action. Br. J. Dermatol. 2010; 163: 269–74. 4 Chiu YE, Drolet BA, Blei F et al. Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon. Pediatr. Blood Cancer 2012; 59: 934–8. 5 Su L, Wang D, Fan X. Comprehensive therapy for hemangioma presenting with Kasabach-Merritt syndrome in the maxillofacial region. J. Oral Maxillofac. Surg. 2015; 73: 92–8.
               
Click one of the above tabs to view related content.